Short Interest in Click Holdings Limited (NASDAQ:CLIK) Drops By 44.7%

Click Holdings Limited (NASDAQ:CLIK) was the recipient of a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 1,704 shares, a drop of 44.7% from the February 12th total of 3,083 shares. Based on an average daily volume of 11,219 shares, the short-interest ratio is currently 0.2 days. Currently, 0.1% of the company’s shares are short sold. Currently, 0.1% of the company’s shares are short sold. Based on an average daily volume of 11,219 shares, the short-interest ratio is currently 0.2 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Click in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Click currently has an average rating of “Sell”.

Click Stock Performance

Shares of Click stock traded down $0.36 on Friday, reaching $3.23. 1,300,902 shares of the company were exchanged, compared to its average volume of 10,353. Click has a 1-year low of $3.01 and a 1-year high of $102.90. The stock’s 50 day moving average price is $4.14 and its 200-day moving average price is $6.33.

About Click

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.